Multi‐omics analysis identifies pathways and genes involved in diffuse‐type gastric carcinogenesis induced by E‐cadherin, p53, and Smad4 loss in mice
- 23 March 2018
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 57 (7) , 947-954
Abstract
The molecular mechanisms underlying the pathogenesis of diffuse‐type gastric cancer (DGC) have not been adequately explored due to a scarcity of appropriate animal models. A recently developed tool well suited for this line of investigation is the Pdx‐1‐Cre;Cdh1F/+;Trp53F/F;Smad4F/F (pChePS) mouse model that spontaneously develops metastatic DGC showing nearly complete E‐cadherin loss. Here, we performed a proteogenomic analysis to uncover the molecular changes induced by the concurrent targeting of E‐cadherin, p53, and Smad4 loss. The gene expression profiles of mouse DGCs and in vivo gastric phenotypes from various combinations of gene knockout demonstrated that these mutations collaborate to activate cancer‐associated pathways to generate aggressive DGC. Of note, WNT‐mediated epithelial‐to‐mesenchymal transition (EMT) and extracellular matrix (ECM)‐cytokine receptor interactions were prominently featured. In particular, the WNT target gene osteopontin (OPN) that functions as an ECM cytokine is highly upregulated. In validation experiments, OPN contributed to DGC stemness by promoting cancer stem cell (CSC) survival and chemoresistance. It was further found that Bcl‐xL acts as a targetable downstream effector of OPN in DGC CSC survival. In addition, Zeb2 and thymosin‐β4 (Tβ4) were identified as prime candidates as suppressors of E‐cadherin expression from the remaining Cdh1 allele during DGC development. Specifically, Tβ4 suppressed E‐cadherin expression and anoikis while promoting cancer cell growth and migration. Collectively, these proteogenomic analyses broaden and deepen our understanding of the contribution of key driver mutations in the stepwise carcinogenesis of DGC through novel effectors, namely OPN and Tβ4.Keywords
Funding Information
- National Research Foundation of Korea (NRF‐2017M3C9A5031597)
- Seoul National University
This publication has 31 references indexed in Scilit:
- Prognostic Value of Cancer Stem Cell Marker CD133 Expression in Gastric Cancer: A Systematic ReviewPLOS ONE, 2013
- Tumor glycolysis as a target for cancer therapy: progress and prospectsMolecular Cancer, 2013
- Glucose Oxidation Modulates Anoikis and Tumor MetastasisMolecular and Cellular Biology, 2012
- ZEB2 Promotes the Metastasis of Gastric Cancer and Modulates Epithelial Mesenchymal Transition of Gastric Cancer CellsDigestive Diseases and Sciences, 2012
- Turnover of Focal Adhesions and Cancer Cell MigrationInternational Journal of Cell Biology, 2012
- A Pathway for the Control of Anoikis Sensitivity by E-Cadherin and Epithelial-to-Mesenchymal TransitionMolecular and Cellular Biology, 2011
- Roles of inflammatory cytokines in the progression of gastric cancer: friends or foes?Gastric Cancer, 2010
- Mouse gastric tumor models with prostaglandin E2 pathway activation show similar gene expression profiles to intestinal-type human gastric cancerBMC Genomics, 2009
- Small molecule antagonists of Tcf4/β‐catenin complex inhibit the growth of HCC cells in vitro and in vivoInternational Journal of Cancer, 2009
- Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote MetastasisCancer Cell, 2008